Product information
From Health Canada
Current status:
Approved
Current status date:
2020-06-19
Product name:
DOCUSATE SODIUM
DIN:
02500922 Electronic product monograph is not available
Company:
ANGITA PHARMA INC.
1310 Rue Nobel
Boucherville
Quebec
Canada
J4B 5H3
Class:
Human
Dosage form(s):
Capsule
Route(s) of administration:
Oral
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
56:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A06AA02 DOCUSATE SODIUM
Active ingredient group (AIG) number:See footnote5
0104351002
Active ingredient(s) | Strength |
---|---|
DOCUSATE SODIUM | 100 MG |